| Literature DB >> 35205065 |
Jasper Chrysolite Paul1, Helena Fulka1.
Abstract
Lamins are essential components of the nuclear envelope and have been studied for decades due to their involvement in several devastating human diseases, the laminopathies. Despite intensive research, the molecular basis behind the disease state remains mostly unclear with a number of conflicting results regarding the different cellular functions of nuclear lamins being published. The field of developmental biology is no exception. Across model organisms, the types of lamins present in early mammalian development have been contradictory over the years. Due to the long half-life of the lamin proteins, which is a maternal factor that gets carried over to the zygote after fertilization, investigators are posed with challenges to dive into the functional aspects and significance of lamins in development. Due to these technical limitations, the role of lamins in early mammalian embryos is virtually unexplored. This review aims in converging results that were obtained so far in addition to the complex functions that ceases if lamins are mutated.Entities:
Keywords: development; laminopathies; maternal factors; nuclear lamins; preimplantation embryo
Year: 2022 PMID: 35205065 PMCID: PMC8869099 DOI: 10.3390/biology11020198
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1The schematic representation of the basic nuclear organization.
Some of the defects and irregularities caused by the mutations in lamins.
| Disease | Lamin Mutations |
|---|---|
| Emery-Dreifuss muscular dystrophy (EDMD) |
X- linked recessive disorder, Emerin (STA) mutation [ Mutation in Lamin A/C produced by the alternate splicing of |
| Mandibuloacral dysplasia and partial lipodystrophy | Homozygous missense mutation, Arg527His, in |
| Mandibuloacral dysplasia with type A lipodystrophy (MADA) | Homozygous mutation in R527H in the |
| Restrictive dermopathy (RD) |
Dominant RD with ZMPSTE4 mutation—a complete absence of Lamin A protein—also a factor to identify lethal neonatal laminopathy |
| Hutchinson- Gilford progeria syndrome (HGPS) |
Single point mutation in Recurrent |
| Limb Girdle muscular dystrophy type 1B (LGMD1B) | Mutation linked to the chromosome 1q11-q21 of |
| Dilated cardiomyopathy (DCM) | R89L, 959delT, R337H, S573L mutation in |
| Autosomal recessive axonal Charcot-Marie-Tooth type 2 (CMT2) | R298C mutation in lamin A/C [ |
| Dunnigan type familial partial lipodystrophy (FPLD) | R482Q mutation in lamin A/C, mutation in the gene mapped to chromosome 1q21-22 encoding for the |
| Adult autosomal dominant leukodystrophy (movement disorder) | Associated with increase or accumulation of lamin B1 [ |
| Primary microcephaly (neuro—developmental disorder) | Heterozygous dominant pathogenic variants in both lamin B1 and lamin B2 [ |
| Progressive myoclonus epilepsy including the early identification of ataxia | Rare and novel homozygous missense p.His157Tyr mutation in the alpha- helical rod of the lamin B2 protein [ |
| Acquired partial lipodystrophy (APL) | Mutation in the |
Figure 2The pictorial representation of the technical challenges that could be encountered.